All In Biotech

Free tool

FAERS Monitor: Dilantin-125

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 008762 or its brand name (Dilantin-125, Phenytoin). Reports on generic versions are filed under their own applications.

Reports

20,902

Serious

18,748

90% of reports

Hospitalization

8,547

Death reported

2,991

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,771
  • drug interaction1,580
  • seizure1,426
  • toxicity to various agents1,372
  • convulsion1,260
  • off label use1,140
  • status epilepticus812
  • stevens-johnson syndrome771
  • pyrexia686
  • fall618
  • dizziness606
  • drug reaction with eosinophilia and systemic symptoms603
  • condition aggravated584
  • somnolence553
  • epilepsy546

Reports by year received

View as table
YearReports
2004569
2005621
2006433
2007499
2008682
2009659
2010895
20111,213
20121,038
20131,000
2014907
2015989
2016929
20171,102
20181,201
20191,250
20201,232
20211,121
20221,114
20231,131
2024988
2025867
2026462

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,257 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
status epilepticusSignal81277.972.657,167
stevens-johnson syndromeSignal77136.133.625,391
drug reaction with eosinophilia and systemic symptomsSignal60324.122.313,046
convulsionSignal1,26022.621.525,547
epilepsySignal54618.316.88,755
seizureSignal1,42612.611.915,064
drug interactionSignal1,58010.19.612,933
toxicity to various agentsSignal1,3728.27.88,727
somnolenceSignal5532.82.5627
drug ineffectiveSignal2,7712.12.01,740
pyrexia6862.01.9345
condition aggravated5841.91.8266
fall6181.91.7253
off label use1,1401.31.287
dizziness6061.21.125

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.